TITLE

Treatment of dilated cardiomyopathy

AUTHOR(S)
Bennett, Tina
PUB. DATE
June 2014
SOURCE
British Journal of Cardiac Nursing;Jun2014, Vol. 9 Issue 6, p297
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Dilated cardiomyopathy is a multi-factorial heart muscle disease with approximately 25% of identified cases being of a familial nature. Patients may be without symptoms for a number of years and their first presentation may be as a sudden death. Family screening is a key tool in early diagnosis and treatment of familial disease, with mutation analysis being used to enable predictive testing in some cases. Early identification of reduced heart function can be treated with established heart failure medical therapies to slow the progression of the disease. Increasingly, cardiac resynchronisation therapy (CRT) is being used to improve heart function in suitable cases and implantable cardioverter defibrillators (ICDs) are used to reduce the risk of sudden cardiac death. Those with severe heart failure may be suitable for a left-ventricular assist device (LVAD) or heart transplantation.
ACCESSION #
96341822

 

Related Articles

  • Wearable defibrillator use in heart failure (WIF): results of a prospective registry. Kao, Andrew C; Krause, Steven W; Handa, Rajiv; Karia, Darshak; Reyes, Guillermo; Bianco, Nicole R; Szymkiewicz, Steven J // BMC Cardiovascular Disorders;2012, Vol. 12 Issue 1, p1 

    Background: Heart failure (HF) patients have a high risk of death, and implantable cardioverter defibrillators (ICDs) are effective in preventing sudden cardiac death (SCD). However, a certain percentage of patients may not be immediate candidates for ICDs, particularly those having a short...

  • The Diagnosis and Treatment of Hypertrophic Cardiomyopathy. Prinz, Christian; Farr, Martin; Hering, Detlef; Horstkotte, Dieter; Faber, Lothar // Deutsches Aerzteblatt International;4/1/2011, Vol. 108 Issue 13, p209 

    Background: Hypertrophic cardiomyopathy (HCM) is the most common hereditary disease of the heart. Methods: In this article, we summarize the current state of the diagnosis and treatment of HCM on the basis of a selective review of recent publications with relevance to clinical practice. Results:...

  • Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Merlo, Marco; Pivetta, Alberto; Pinamonti, Bruno; Stolfo, Davide; Zecchin, Massimo; Barbati, Giulia; Di Lenarda, Andrea; Sinagra, Gianfranco // European Journal of Heart Failure;Mar2014, Vol. 16 Issue 3, p317 

    Aims ACE-inhibitors, β-blockers, implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) improved prognosis of heart failure. We sought to analyse the long-term prognostic impact of evidence-based integrated therapeutic strategies in patients with idiopathic...

  • NICE guidelines for use of implantable cardioverter defibrillators. Saberwal, Bunny; Ahsan, Syed // British Journal of Hospital Medicine (17508460);2015 Supplement, Vol. 76, p316 

    The authors talk about guidelines set by Great Britain's National Institute for Health and Care Excellence (NICE) regarding the use of implantable cardioverter defibrillator which can prevent sudden cardiac death caused by ventricular arrhythmias. Topics discussed include conditions for...

  • I wouldn't be here without my heart pump. McCluskey, Mark // British Journal of Cardiac Nursing;Aug2013, Vol. 8 Issue 8, p401 

    A personal narrative is presented which explores the author's experience of living with a left ventricular assist device since July 2011 while he waits for a heart transplant.

  • Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome. Kawecki, Damian; Dola, Janusz; Jacheć, Wojciech; Wojciechowska, Celina; Morawski, Stanisław; Tomasik, Andrzej; Nowalany-Kozielska, Ewa // Open Medicine;2015, Vol. 10 Issue 1, p-1 

    Long QT syndrome (LQTS) is characterised by both the depolarisation and repolarisation disorder of cardiac muscle cells. Cardiac resynchronising therapy (CRT) is an important treatment option for patients with chronic heart failure (CHF) when echocardiographic and electrocardiographic criteria...

  • Impact of left ventricular lead position on the incidence of ventricular arrhythmia and clinical outcome in patients with cardiac resynchronization therapy. Kleemann, Thomas; Becker, Torsten; Strauss, Margit; Dyck, Ngoc; Schneider, Steffen; Weisse, Udo; Saggau, Werner; Cornelius, Bernd; Layer, Günter; Seidl, Karlheinz // Journal of Interventional Cardiac Electrophysiology;Aug2010, Vol. 28 Issue 2, p109 

    The aim of the study was to evaluate the incidence of ventricular arrhythmia and clinical outcome in patients receiving a cardiac resynchronization therapy (CRT) depending on the left ventricular (LV) lead position. A total of 187 consecutive patients with advanced heart failure who received a...

  • Study Reveals Optimal Use of Cardiac Resychronization. DiMarco, John P. // Clinical Cardiology Alert;Feb2011, Vol. 30 Issue 2, p13 

    The article discusses a research paper by A.S.L. Tang and colleagues which highlights the results of the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). The study examined the effect of cardiac-resynchronization therapy (CRT) and implantable...

  • Vacuum-assisted closure for skin infection in a patient with Berlin Heart Excor biventricular assist device. Oto, Öztekin; Metin, Sadık Kıvanç; Bal, Melih; Özserim, Gökçen; Uğurlu, Baran Şevket // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Feb2013, Vol. 13 Issue 1, p77 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics